tiprankstipranks
Grounded Lithium (TSE:GRD)
TSXV:GRD
Holding TSE:GRD?
Track your performance easily

Grounded Lithium (GRD) Stock Price & Analysis

4 Followers

GRD Stock Chart & Stats


Financials

Annual

Options Prices

Currently, No data available
---

Ownership Overview

0.04%99.96%
Insiders
Mutual Funds
0.04% Other Institutional Investors
99.96% Public Companies and
Individual Investors

GRD FAQ

What was Grounded Lithium’s price range in the past 12 months?
Grounded Lithium lowest stock price was C$0.03 and its highest was C$0.11 in the past 12 months.
    What is Grounded Lithium’s market cap?
    Currently, no data Available
    When is Grounded Lithium’s upcoming earnings report date?
    Grounded Lithium’s upcoming earnings report date is Apr 23, 2025 which is in 122 days.
      How were Grounded Lithium’s earnings last quarter?
      Grounded Lithium released its earnings results on Nov 20, 2024. The company reported -C$0.002 earnings per share for the quarter, missing the consensus estimate of N/A by -C$0.002.
        Is Grounded Lithium overvalued?
        According to Wall Street analysts Grounded Lithium’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Grounded Lithium pay dividends?
          Grounded Lithium does not currently pay dividends.
          What is Grounded Lithium’s EPS estimate?
          Grounded Lithium’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does Grounded Lithium have?
          Grounded Lithium has 70,889,946 shares outstanding.
            What happened to Grounded Lithium’s price movement after its last earnings report?
            Grounded Lithium reported an EPS of -C$0.002 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -8.333%.
              Which hedge fund is a major shareholder of Grounded Lithium?
              Currently, no hedge funds are holding shares in TSE:GRD
              ---

              Grounded Lithium Stock Smart Score

              10
              Unlock Smart Score
              1
              2
              3
              4
              5
              6
              7
              8
              9
              10

              Technicals

              SMA
              Positive
              20 days / 200 days
              Momentum
              -50.79%
              12-Months-Change

              Fundamentals

              Return on Equity
              -60.96%
              Trailing 12-Months
              Asset Growth
              -35.50%
              Trailing 12-Months

              Company Description

              Grounded Lithium

              Canadian International Pharma Corp is a Canada based pharmaceutical company. It is engaged in generic drug manufacturing and distribution business. The pharmaceutical products of the company are Acetaminophen, Betamethasone, Biperiden, Tetracycline, Simvastatin, Pediatric Multivitamin, and others. Its nutraceutical products offered by the group are Activated Charcol capsules, Bilberry capsules, Collatol capsules, Fish Oil Softgels, Melatonin Softgels, Wild Salmon Oil Softgels, and others. The company also provides medications with a private label based on client requests. In addition, it also offers primary and secondary packaging for tablet, capsules and other forms of medications.
              ---
              Similar Stocks
              Company
              Price & Change
              Follow
              Albemarle
              Sociedad Quimica Y Minera SA
              FMC
              Lithium Americas Corp.
              Grounded Lithium
              Popular Stocks
              ---
              What am I Missing?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis